Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01435681 · ClinicalTrials.gov registry record
Can Short Latency Afferent Inhibition Give us Clues to Better DYT 1 Dystonia Treatments?
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 5
- Enrollment target
NCT01435681: Completed study, sponsored by University of Florida.
NCT01435681 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01435681 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
This is a research study using transcranial magnetic stimulation (TMS) to investigate interactions between the sensory system and the motor cortex in primary generalized dystonia (DYT1 dystonia) subjects who undergo deep brain stimulation (DBS) surgery. The sensory system is the body's sense organs - smell, sight, sound, etc. - and the motor cortex is the part of your brain where nerve impulses control voluntary muscle activity.
Primary Outcome
Surface electromyography (EMG) will be recorded from the first dorsal interosseous muscle to determine the amplitude of potentials evoked in two ways - SAI and SAIdualstim. For SAI, potentials will be evoked with median nerve stimulation preceding TMS by the N20 latency plus 3 ms. For SAI dualstim, simultaneous stimulation of median and ulnar nerves will precede TMS by the N20 latency plus 3 ms.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2012-05 |
| Est. Completion | 2016-08 |
What the finished NCT01435681 record still lists
NCT01435681 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01435681 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01435681 about?
NCT01435681 is a clinical study titled "Can Short Latency Afferent Inhibition Give us Clues to Better DYT 1 Dystonia Treatments?". This is a research study using transcranial magnetic stimulation (TMS) to investigate interactions between the sensory system and the motor cortex in primary generalized dystonia (DYT1 dystonia) subjects who undergo deep brain stimulation (DBS) surgery. The sensory system is the body's sense organs...
What is the current status of trial NCT01435681?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2012-05. Estimated completion is 2016-08.
Who is sponsoring clinical trial NCT01435681?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia